2 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Pemphigus: new trials by email Literature Review of Pemphigus trials Research Report on Pemphigus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of B007 in the Treatment of Pemphigus. B007 - Pemphigus | Phase 2 / Phase 3 | Recruiting | Shanghai Jiaolian Drug Research and Development Co., Ltd | 132 | 2024-07-12 | 2026-05-05 |
| A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) DSG3-CAART, CABA-201 - Pemphigus Vulgaris | Phase 1 / Phase 2 | Recruiting | Cabaletta Bio | 40 | 2020-09-29 | 2026-10-15 |
Autoimmune Diseases (1) · Immune System Diseases (1) · Skin Diseases, Vesiculobullous (1)
Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Autoimmune Diseases (1) · Immune System Diseases (1) · Skin Diseases, Vesiculobullous (1)
Cabaletta Bio (1) · Shanghai Jiaolian Drug Research and Development Co., Ltd (1)
China (1) · United States (1)
Cabaletta Bio (1)